心脏科设备类 | Cardiology devices
| AtCor Medical Pty Ltd | |
| AtCor Medical 是一家集设计，制造和销售心血管管理类产品的全球性医疗器械公司。SphygmoCor系列产品可对中心动脉压，动脉僵硬度及植物神经功能等心血管系统进行功能性的无创评估。 | AtCor Medical designs, manufactures, and markets medical devices for use in cardiovascular management worldwide. The SphygmoCor system family of products provides tools for non-invasive assessment of the cardiovascular system function, focused on central blood pressures, measures of arterial stiffness and autonomic function. |
| 更多信息 | More information |
| Cardiac Dimensions Pty Ltd (CDI) | |
| CDI 是一家医疗设备公司，致力于开发和商品化新型非手术装置“Carillon”，专用于治疗功能性二尖瓣闭锁不全所引起的相关病症及心脏衰竭。 | CDI is a medical device company that has been developing and commercialising a novel, non-surgical device (the “Carillon”) for the treatment of heart failure and specifically the related condition of functional mitral valve regurgitation. |
| 更多信息 | More information |
| Medtronic Australasia Pty Ltd | |
| 美敦力澳大拉西亚有限公司是母公司美国美敦力公司 (Medtronic plc) 在澳大利亚/新西兰的子公司。 在美敦力，我们致力于创新生活，不断扩展医疗技术的范围并改变世界治疗慢性疾病的方式。 | Medtronic Australasia is the Australia/New Zealand subsidiary of parent company, Medtronic plc. At Medtronic, we're committed to Innovating for life by pushing the boundaries of medical technology and changing the way the world treats chronic disease. |
| 更多信息 | More information |
| Osprey Medical Inc. | |
| Osprey Medical的核心技术来自于墨尔本Baker IDI心脏和糖尿病研究所David Kaye博士所做的研究。Osprey专注于保护慢性肾病患者不患由造影剂引发的肾病(CIN)，防止糖尿病患者因重度足部感染而引发的截肢，从而提高患者的生活质量。 | Osprey Medical's core technologies originated from research conducted by Dr David Kaye at Melbourne’s Baker IDI Heart and Diabetes Institute. Osprey is focused on improving patients’ quality of life by protecting those with chronic kidney disease from contrast induced nephropathy (CIN) and preventing limb amputation in diabetic patients with advanced foot infections. |
| 更多信息 | More information |
神经科设备类 | Neurology devices
| Biosensis Pty Ltd | |
| Biosensis 是一家为生命科学研发市场提供抗体类试剂的公司。 | Biosensis is a provider of antibody-based reagents for the life science, research market. |
| 更多信息 | More information |
| Global Kinetics Corporation (GKC) | |
| GKC 成立于2007年，是一家总部位于澳大利亚墨尔本的医药科技公司，其主打产品为Parkinson’s KinetiGraph (PKG)。 帕金森病所表现出的主要运动失调症状为运动迟缓和运动障碍，对于这种病症的存在及严重程度，PKG能够为临床神经学专科医生提供一份详尽的报告。 | Established in 2007, GKC’s lead product is the Parkinson’s KinetiGraph (PKG). The PKG provides treating neurologists with a detailed report about the presence and severity of the key disabling movement disorders of Parkinson’s disease – bradykinesia and dyskinesia. |
| 更多信息 | More information |
| Neural Diagnostics Pty Ltd | |
| Neural Diagnostics 股份有限公司(ND) 运营于年产值数十亿美元的全球神经技术市场，为需花费数兆的精神与神经疾病提供服务。 | Neural Diagnostics Pty Ltd (ND) operates in the multi-billion dollar global annual neuro-technology market servicing the multi-trillion cost burden of disease of mental and neurological conditions. |
| 更多信息 | More information |
| NIESM Pty Ltd | |
| NIESM 有限责任公司，成立于2013年10月。本公司研制的软硬件集成解决方案可以帮助临床医生对癫痫患者的发病状态进行监测和管理。我们正在开发一种可穿戴的传感系统。 | NIESM Pty Ltd was formed in October 2013 to develop an integrated hardware/software solution that would help the clinician in managing the seizure state of the patient with epilepsy. |
| 更多信息 | More information |